| Literature DB >> 2785798 |
T Tanaka1, O Saiki, S Negoro, T Igarashi, T Kuritani, H Hara, M Suemura, S Kishimoto.
Abstract
Using radiolabeled interleukin-2 (IL-2), affinity cross-linking and binding assays revealed that the expression of intermediate-affinity IL-2 binding molecules (p70/75) on freshly prepared T cells from patients with systemic lupus erythematosus (SLE) was significantly decreased in comparison with that in normal subjects. The proliferative response of T cells to high doses of IL-2 was also reduced in patients with SLE. The decreased expression of p70/75 reflects the hyporesponsiveness to IL-2 of T cells in patients with SLE.Entities:
Mesh:
Substances:
Year: 1989 PMID: 2785798 DOI: 10.1002/anr.1780320507
Source DB: PubMed Journal: Arthritis Rheum ISSN: 0004-3591